Fujifilm expands gene therapy analytical services with $55m lab

By Vassia Barba

- Last updated on GMT

(Image: Getty/undefined)
(Image: Getty/undefined)

Related tags Fujifilm diosynth biotechnologies Cell therapy cell and gene therapy Gene therapy Process analytical technology

Fujifilm Diosynth opens a 60,000-square-feet Gene Therapy Innovation Center to support upstream, downstream and analytical development services.

The laboratory space will be added to Fujifilm Diosynth Biotechnologies (FDB) gene therapy manufacturing facility in Texas, US, and is expected to boost the company’s offering of process and analytical development services for gene therapies developers.

The establishment of the laboratory space, which will cost the company $55m (€49.65m), is part of a total investment of ¥13bn ($120m) made by Fujifilm Corporation, as part of the company’s effort to meet the growing demands of the market.

“We need to invest now, in technology, assets and people,” ​commented Martin Meeson, president and COO of FDB for the US, adding that the company is ‘very much aware’ of the gene therapy market’s ‘incredible’ growth.

The facility is expected to be operational in the fall of 2021 and will add approximately 100 jobs to the company’s College Station campus in Texas.

FDB’s 80,000-square-feet plant in Texas opened early last year​, with the company looking to tap into the booming cell and gene therapies space, and provide clinical and commercial manufacturing capabilities for developers.

Earlier this year, Meeson told us that the increase of assets has led the company to establish new partnerships, with interest continuously rising, and mentioned that, at that point, the Texas facility was ‘easily expandable’ to help the company answer such demand.

Related news

Show more

Related products

show more

Process optimization for mAb commercial manufacturing

Process optimization for mAb commercial manufacturing

Content provided by Catalent | 01-Jun-2023 | Product Presentation

Process characterization and validation is an important step in the product development journey and late-phase development, and it is required before transferring...

Riding the mRNA Highway

Riding the mRNA Highway

Content provided by Thermo Fisher Scientific - Biosciences | 15-May-2023 | White Paper

Learn more about process development and manufacturing in the mRNA space to enable successful scale-ups of mRNA production for therapeutic applications.

eBook: mRNA prospects and scale-up solutions

eBook: mRNA prospects and scale-up solutions

Content provided by Thermo Fisher Scientific - Biosciences | 22-Mar-2023 | Insight Guide

This mRNA eBook was created by Thermo Fisher Scientific, in collaboration with Genetic Engineering & Biotechnology News (GEN), to provide you with...

Related suppliers

Follow us

Products

View more

Webinars